Carey Macrury is an analyst from Canaccord Genuity They are beginning to establish their track record, with 1 stock rating so far. Their current stats show a success rate of 100.00 % and an average ...

Brian Abrahams of RBC Capital initiated an “Outperform” rating for Vertex Pharmaceuticals Incorporated (VRTX), paving the way for potential upside for investors. With a current price of $461.14 and a ...

Zoetis Inc. (NYSE: ZTS) was assigned a “Neutral” rating by analyst David Westenberg from Piper Sandler. This rating comes with a price target of $135, suggesting an upside potential from the current ...

Simmons First National Corporation (SFNC) has garnered renewed attention following an “Outperform” rating from David Feaster of Raymond James, effective. This upgrade is particularly notable given the ...

Public Service Enterprise Group Incorporated (PEG) received a Neutral rating from analyst Jeremy Tonet of JP Morgan, despite a price target of $85. This marks a significant shift in sentiment, which ...

Gold Royalty Corp. (GROY) has garnered attention following a recent rating adjustment from Carey MacRury of Canaccord Genuity, who on January 22, 2026, downgraded the stock to a Hold. This adjustment ...

Amicus Therapeutics, Inc. (NASDAQ: FOLD) received a “Hold” rating from Dennis Ding at Jefferies. The firm set a price target of $14.50, slightly above the current trading price of $14.35. This ...

Enhabit, Inc. (EHAB) is garnering investor attention following a recent upgrade to an “Outperform” rating by Michael Wiederhorn of Oppenheimer o. This rating upgrade comes amid encouraging financial ...

Callaway Golf Company (CALY) received a “Buy” rating from Anna Glaessgen of B. Riley Securities, which has sparked renewed interest among investors. This rating, coupled with a price target set at $19 ...

Abercrombie & Fitch Co. (ANF) caught investors’ attention recently when Paul Lejuez of Citigroup initiated coverage with a “Buy” rating o. The rating suggests a promising outlook for the iconic ...

In a recent development, RAPT Therapeutics, Inc. (RAPT) received an Equal-Weight rating from Barclays analyst Etzer Darout o. This recommendation comes with a price target of $58, suggesting a slight ...

Rothschild & Co analyst Oliver Holmes assigned a “Neutral” rating to FedEx Corporation (FDX), signaling a cautious outlook for the company as its stock struggles to gain significant momentum. With the ...